Combined right and left ventricular mechanical dispersion enhance the arrhythmic risk stratification in hypertrophic

Nicoleta-Monica Popa-Fotea1, Miruna Mihaela Micheu2, Sebastian Onciul1

  • 1Department of Cardiology, Clinical Emergency Hospital of Bucharest, Bucharest, Romania; University of Medicine and Pharmacy Carol Davila, Bucharest, Romania.

Insights

Mechanical dispersion in hypertrophic cardiomyopathy (HCM) patients correlates with ventricular arrhythmias. Combined left and right ventricular mechanical dispersion may improve risk stratification for HCM patients with non-sustained ventricular tachycardia.

Area of Science:

  • Cardiology
  • Cardiac Electrophysiology
  • Medical Imaging

Background:

  • Ventricular arrhythmias are a primary cause of sudden cardiac death in hypertrophic cardiomyopathy (HCM).
  • Assessing mechanical dispersion (MD) in both ventricles may offer new insights into arrhythmia risk.

Purpose of the Study:

  • To investigate the correlation between combined left ventricular (LV) and right ventricular (RV) mechanical dispersion (MD) and ventricular arrhythmias in HCM.
  • To determine if MD enhances arrhythmic risk stratification in HCM patients.

Main Methods:

  • 47 HCM patients and 36 healthy controls underwent ECG monitoring and transthoracic echocardiography with strain rate imaging.
  • LV and RV mechanical dispersion (MD) calculated as standard deviation of time from R wave peak to maximum ventricular shortening.
  • Non-sustained ventricular tachycardia (NSVT) characterized by number, rate, and duration.

Main Results:

  • HCM patients with NSVT exhibited significantly increased LVMD and RVMD compared to those without NSVT and healthy controls.
  • Optimal cut-off values for LVMD and RVMD were identified as 62ms and 39ms, respectively.
  • LVMD and RVMD were independent predictors of NSVT and improved risk stratification.

Conclusions:

  • Increased LV and RV mechanical dispersion correlate with the presence of NSVT in HCM patients.
  • Combined LV and RV mechanical dispersion can enhance the risk stratification of HCM patients with NSVT.
Abstract

Related Concept Videos

Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
263
Cardiomyopathy I: Introduction and Classification01:25

Cardiomyopathy I: Introduction and Classification

Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
383
Mitral Regurgitation I: Introduction01:20

Mitral Regurgitation I: Introduction

Mitral regurgitation is characterized by the backward circulation of blood from the left ventricle to the left atrium during systole, a phase of the cardiac cycle when the heart contracts and pumps blood out of the chambers. This abnormal flow occurs primarily due to the dysfunction of the mitral valve or its supporting structures, which include the mitral leaflets, chordae tendineae, annulus, and papillary muscles.Etiology and Mechanisms:Primary Mitral Regurgitation: This type arises from...
259
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
575
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
214
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
319